Regulation of cytokine responses by seasonality of vitamin D status in healthy individuals

Clinical and Experimental Immunology

Volumn 164, Issue 1, 2011, Pages 72-79

  Khoo, A L ^a,b   Chai, L Y A ^b,c   Koenen, H J P M ^a,b   Sweep, F C G J ^b   Joosten, I ^a,b   Netea, M G ^b   van der Ven, A J A M ^b  

^a Laboratory Medical Immunology   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

Author keywords

1,25 dihydroxyvitamin D3; Innate immunity; Proinflammatory; Toll like receptors

Indexed keywords

CALCITRIOL; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELL ISOLATION; CELL STIMULATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOWN REGULATION; FLOW CYTOMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOMODULATION; IN VITRO STUDY; INNATE IMMUNITY; MALE; NORMAL HUMAN; NUTRITIONAL STATUS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEASONAL VARIATION; VITAMIN BLOOD LEVEL;

ADULT; CALCITRIOL; CYSTEINE; CYTOKINES; DOWN-REGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-1BETA; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; MALE; MIDDLE AGED; SEASONS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA; VITAMINS;

EID: 79952492953     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2010.04315.x     Document Type: Article

References (43)

1. Veldman CM, Cantorna MT, DeLuca HF. Expression of 1, 25-dihydroxyvitamin D(3) receptor in the immune system. Arch Biochem Biophys 2000; 374:334-8.
2. Mahon BD, Wittke A, Weaver V, Cantorna MT. The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells. J Cell Biochem 2003; 89:922-32.
3. Provvedini DM, Tsoukas CD, Deftos LJ, Manolagas SC. 1, 25-dihydroxyvitamin D3 receptors in human leukocytes. Science 1983; 221:1181-3.
4. Mora JR, Iwata M, von Andrian UH. Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol 2008; 8:685-98.
5. Adams JS, Hewison M. Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab 2008; 4:80-90.
6. 3 modulates cytokine production induced by Candida albicans: impact of seasonal variation of immune responses. J Infect Dis 2011; 203:122-30.
7. Baeke F, van EE, Gysemans C, Overbergh L, Mathieu C. Vitamin D signaling in immune-mediated disorders: evolving insights and therapeutic opportunities. Mol Aspects Med 2008; 29:376-87.
8. Yamshchikov AV, Desai NS, Blumberg HM, Ziegler TR, Tangpricha V. Vitamin D for treatment and prevention of infectious diseases: a systematic review of randomized controlled trials. Endocr Pract 2009; 15:438-49.
9. Webb AR, Holick MF. The role of sunlight in the cutaneous production of vitamin D3. Annu Rev Nutr 1988; 8:375-99.
10. Lips P. Vitamin D physiology. Prog Biophys Mol Biol 2006; 92:4-8.
11. Guillemant J, Taupin P, Le HT etal. Vitamin D status during puberty in French healthy male adolescents. Osteoporos Int 1999; 10:222-5.
12. Reusch J, Ackermann H, Badenhoop K. Cyclic changes of vitamin D and PTH are primarily regulated by solar radiation: 5-year analysis of a German (50 degrees N) population. Horm Metab Res 2009; 41:402-7.
13. Lips P. Worldwide status of vitamin D nutrition. J Steroid Biochem Mol Biol 2010; 121:297-300.
14. Ponsonby AL, McMichael A, van dM I. Ultraviolet radiation and autoimmune disease: insights from epidemiological research. Toxicology 2002; 181-182:71-8.
15. Alonso A, Hernan MA. Temporal trends in the incidence of multiple sclerosis: a systematic review. Neurology 2008; 71:129-35.
16. Fernandes de Abreu DA, Babron MC, Rebeix I etal. Season of birth and not vitamin D receptor promoter polymorphisms is a risk factor for multiple sclerosis. Mult Scler 2009; 15:1146-52.
17. Willer CJ, Dyment DA, Sadovnick AD, Rothwell PM, Murray TJ, Ebers GC. Timing of birth and risk of multiple sclerosis: population based study. BMJ 2005; 330:120.
18. Moltchanova EV, Schreier N, Lammi N, Karvonen M. Seasonal variation of diagnosis of Type 1 diabetes mellitus in children worldwide. Diabet Med 2009; 26:673-8.
19. Cannell JJ, Vieth R, Umhau JC etal. Epidemic influenza and vitamin D. Epidemiol Infect 2006; 134:1129-40.
20. Grant WB. Variations in vitamin D production could possibly explain the seasonality of childhood respiratory infections in Hawaii. Pediatr Infect Dis J 2008; 27:853.
21. Sabetta JR, DePetrillo P, Cipriani RJ, Smardin J, Burns LA, Landry ML. Serum 25-hydroxyvitamin d and the incidence of acute viral respiratory tract infections in healthy adults. PLoS ONE 2010; 5:e11088.
22. Ginde AA, Mansbach JM, Camargo CA Jr. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med 2009; 169:384-90.
23. Laaksi I, Ruohola JP, Tuohimaa P etal. An association of serum vitamin D concentrations < 40nmol/L with acute respiratory tract infection in young Finnish men. Am J Clin Nutr 2007; 86:714-7.
24. Li-Ng M, Aloia JF, Pollack S etal. A randomized controlled trial of vitamin D3 supplementation for the prevention of symptomatic upper respiratory tract infections. Epidemiol Infect 2009; 137:1396-404.
25. Laaksi I, Ruohola JP, Mattila V, Auvinen A, Ylikomi T, Pihlajamaki H. Vitamin D supplementation for the prevention of acute respiratory tract infection: a randomized, double-blinded trial among young Finnish men. J Infect Dis 2010; 202:809-14.
26. Urashima M, Segawa T, Okazaki M, Kurihara M, Wada Y, Ida H. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr 2010; 91:1255-60.
27. Hirschfeld M, Weis JJ, Toshchakov V etal. Signaling by Toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages. Infect Immun 2001; 69:1477-82.
28. van Hoof HJ, Swinkels LM, van Stevenhagen JJ, van den BH, Ross HA, Benraad TJ. Advantages of paper chromatography as a preparative step in the assay of 1, 25-dihydroxyvitamin D. J Chromatogr 1993; 621:33-9.
29. Hollis BW. Assessment of vitamin D nutritional and hormonal status: what to measure and how to do it. Calcif Tissue Int 1996; 58:4-5.
30. Brock K, Huang WY, Fraser DR etal. Low vitamin D status is associated with physical inactivity, obesity and low vitamin D intake in a large US sample of healthy middle-aged men and women. J Steroid Biochem Mol Biol 2010; 121:462-6.
31. Vieth R, Cole DE, Hawker GA, Trang HM, Rubin LA. Wintertime vitamin D insufficiency is common in young Canadian women, and their vitamin D intake does not prevent it. Eur J Clin Nutr 2001; 55:1091-7.
32. Boonstra A, Barrat FJ, Crain C, Heath VL, Savelkoul HF, O'Garra A. 1alpha, 25-Dihydroxyvitamin D3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol 2001; 167:4974-80.
33. Lemire JM, Archer DC, Beck L, Spiegelberg HL. Immunosuppressive actions of 1, 25-dihydroxyvitamin D3: preferential inhibition of Th1 functions. J Nutr 1995; 125:1704S-8S.
34. Daniel C, Sartory NA, Zahn N, Radeke HH, Stein JM. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile. J Pharmacol Exp Ther 2008; 324:23-33.
35. Imazeki I, Matsuzaki J, Tsuji K, Nishimura T. Immunomodulating effect of vitamin D3 derivatives on type-1 cellular immunity. Biomed Res 2006; 27:1-9.
36. Baeke F, Korf H, Overbergh L etal. Human T lymphocytes are direct targets of 1, 25-dihydroxyvitamin D3 in the immune system. J Steroid Biochem Mol Biol 2010; 121:221-7.
37. Matilainen JM, Husso T, Toropainen S etal. Primary effect of 1alpha, 25(OH)(2)D(3) on IL-10 expression in monocytes is short-term down-regulation. Biochim Biophys Acta 2010; 1803:1276-86.
38. Sadeghi K, Wessner B, Laggner U etal. Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns. Eur J Immunol 2006; 36:361-70.
39. Vieth R. What is the optimal vitamin D status for health? Prog Biophys Mol Biol 2006; 92:26-32.
40. Chai LY, Kullberg BJ, Vonk AG etal. Modulation of Toll-like receptor 2 (TLR2) and TLR4 responses by Aspergillus fumigatus. Infect Immun 2009; 77:2184-92.
41. Chadha MK, Fakih M, Muindi J etal. Effect of 25-hydroxyvitamin D status on serological response to influenza vaccine in prostate cancer patients. Prostate 2011; 71:368-72.
42. Kriesel JD, Spruance J. Calcitriol (1, 25-dihydroxy-vitamin D3) coadministered with influenza vaccine does not enhance humoral immunity in human volunteers. Vaccine 1999; 17:1883-8.
43. Simpson S Jr, Taylor B, Blizzard L etal. Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis. Ann Neurol 2010; 68:193-203.